• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Breast Health

UCLA Breast Health

UCLA Breast Health
  • About Us
    • Contact Us
    • News & Updates
  • Our Expert Team
    • Breast Surgeons
    • Radiation Oncologists
    • Medical Oncologists
    • Plastic Surgeons
    • Breast Imaging
    • Genetic Counselors
    • Breast Pathologists
    • Simms Mann
  • Locations
    • Beverly Hills
    • Burbank
    • Encino
    • Laguna Hills
    • City of Orange
    • Pasadena
    • Porter Ranch
    • Santa Clarita
    • Santa Monica
    • Torrance
    • Westwood
  • For Patients
    • COVID-19
    • Breast Health Information & Guidelines
    • Breast Wire Localization (PDF)
    • What to Expect When Diagnosed with Breast Cancer
    • Managing Your Care
    • Patient Education
    • Patient Stories
    • Share Your Story
    • Breast Health Intake Form
    • Billing
    • Radiology Connection
    • Breast Cancer Awareness Month
  • Breast Health Services
    • Breast Cancer
    • Benign Breast Disease
    • Breast Surgery
    • Breast Reconstruction
    • High Risk Breast Clinic
    • Breast Imaging
    • Radiation Oncology
    • Medical Oncology
    • Breast Pathology
    • Cancer Genetics
  • Research & Education
    • Visual Abstracts
    • Webinars
  • Make a Gift
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Breast Health

Breast Cancer

Breast Cancer

Breast Cancer

  • Risk Factors
  • Diagnosis
  • Treatment
  • DCIS
  • LCIS
  • Risk Factors
  • Diagnosis
  • Treatment
  • DCIS
  • LCIS
  1. Home
  2. Breast Health Services
  3. Breast Cancer
  4. DCIS

Ductal Carcinoma In Situ (DCIS)

Share this

Affiliated: Breast Cancer | Risk Factors | Diagnosis | Treatment | DCIS | LCIS

Find a Location Near You

800-UCLA-MD1 or 310-825-2631

Overview

Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer, meaning that the abnormal cells are contained within the milk ducts of the breast and have not invaded the nearby breast tissue. DCIS cannot spread to the lymph nodes or other parts of the body. Therefore, it is considered stage 0 breast cancer. Although it is not life-threatening, treatment for this stage of disease is recommended because DCIS can turn into invasive breast cancer, which could then be life-threatening. The goal of treatment for DCIS then is to prevent development of invasive breast cancer. It is similar to removing polyps in the colon, which is performed routinely because colon polyps can turn into colon cancer.

Signs and Symptoms

DCIS doesn't typically cause symptoms. However, on occasion DCIS can present as a breast lump or bloody nipple discharge.

Diagnosis

DCIS is usually found on a mammogram and appears as small clusters of calcifications that have irregular shapes and sizes. Prior to routine screening mammogram, we didn’t even know this stage of breast cancer even existed.

If abnormal calcifications are seen on a mammogram, a needle biopsy is recommended to determine if the calcifications are associated with a benign process or a cancerous process in the breast. A needle biopsy prior to surgery is the recommended method of obtaining a diagnosis of breast cancer.

Won’t a Needle Biopsy Cause Cancer Cells to Spread?

Patients are often concerned that the needle biopsy will disrupt and disseminate cancer cells, but this is not the case. Patients who are diagnosed with breast cancer by needle biopsy are not diagnosed at higher stages and do not have a worsened outcome than patients who are diagnosed by a surgical biopsy. Therefore, a needle biopsy is the preferred approach for diagnosing breast cancer.

Treatment

Without treatment DCIS may turn into invasive breast cancer, so DCIS is treated to prevent invasive cancer from forming. Treatment of DCIS may include surgery to remove only the abnormal cells (lumpectomy) followed by possible radiation or surgery to remove all breast tissue (mastectomy). Because DCIS is not an invasive cancer and cannot spread to other parts of the body, whole body treatments, like chemotherapy, are not indicated for this stage of disease. Hormone-blocking therapy may be discussed to reduce the risk of the DCIS returning in the breast because half of the time DCIS can recur as an invasive cancer but it is not necessary for treatment of DCIS. Active monitoring of DCIS as an alternative to surgery is also being studied in a clinical trial.

With treatment, the prognosis of DCIS is excellent.

Contact Us >

Phone: 800-UCLA-MD1 or 310-825-2631

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth